Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 30879 matches for

Professor Michael Dustin and an international team of collaborators have been awarded a €10M grant from the European Research Council (ERC) to develop a new biotechnology around supramolecular attack particles (SMAPs) engineered to kill cancer cells.

Collage of Michael Dustin and Stefan Balint

Trials

Research groups

Clinical Kennedy Trust Prize Studentships

Applications for these projects are now closed. Please visit the website in summer 2026 to see available projects for October 2027 entry.

SITU

Forms library

Files Library

Oxford Trauma

Events

Study with us

Botnar projects

Applications for these projects are now closed. Please visit the website in summer 2026 to see available projects for October 2027 entry.

About us

OPEN ARMS

Jobs

Trials in closure

Trials in follow up

Trials under analysis

Trials open to recruitment

Trials in set-up

Themes

OCTRU runs trials across multiple areas of medicine. Within OCTRU there are five core therapeutic areas of expertise, although trials are also undertaken outside of these areas and groups.

Our studies

Load More

MEET MICHAEL AND STEFAN

Find out more about

Similar stories